Cross-Resistance Analysis of Human Immunodeficiency Virus Type 1 Variants Individually Selected for Resistance to Five Different Protease Inhibitors

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.39.8.1704
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Novel Human Immunodeficiency Virus Type 1 Protease Mutations Potentially Involved in Resistance to Protease Inhibitors

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently Under Development as Microbicides

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2011English

Loss of Viral Fitness Associated With Multiple Gag and Gag-Pol Processing Defects in Human Immunodeficiency Virus Type 1 Variants Selected for Resistance to Protease Inhibitors in Vivo

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1998English

Human Immunodeficiency Virus Type 1 Protease-Correlated Cleavage Site Mutations Enhance Inhibitor Resistance

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2009English

In Vitro Resistance Profile of the Human Immunodeficiency Virus Type 1 Protease Inhibitor BMS-232632

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

In vitroSequential Selection and Characterization of Human Immunodeficiency Virus Type 1 Variants With Reduced Sensitivity to Hydroxyethylurea Protease Inhibitors

Antiviral Chemistry and Chemotherapy
MedicineVirologyDrug DiscoveryPharmacology
1997English

Cyclophilin A, TRIM5, and Resistance to Human Immunodeficiency Virus Type 1 Infection

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2006English

Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected Mutations

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2009English

Estimate of the Frequency of Human Immunodeficiency Virus Type 1 Protease Inhibitor Resistance Within Unselected Virus Populations in Vitro

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy